TickerFactsScreenerDevelopers

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $2.80M2009: $3.24M2010: $8.09M2011: $7.71M2012: $1.22M2013: $15.70M2014: $17.39M2015: $14.18M2016: $1.17M2017: $105.5K2018: $51.0K2019: $590.7K2020: $97.2K2021: $683.0K2022: $21.6K2023: $76.6K2024: $307.4K2025: $251.3K$251.3K
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$251.3K-18.3%
2024$307.4K+301.5%
2023$76.6K+254.4%
2022$21.6K-96.8%
2021$683.0K+602.4%
2020$97.2K-83.5%
2019$590.7K+1058.6%
2018$51.0K-51.7%
2017$105.5K-90.9%
2016$1.17M-91.8%
2015$14.18M-18.5%
2014$17.39M+10.8%
2013$15.70M+1184.8%
2012$1.22M-84.1%
2011$7.71M-4.7%
2010$8.09M+149.8%
2009$3.24M+15.8%
2008$2.80M—